1st patients enrolled in NuVasive XLIF advanced material implant study: 3 notes

Written by Shayna Korol | September 26, 2018 | Print  |

NuVasive enrolled the first patients in its study comparing lateral lumbar interbody fusion outcomes with traditional smooth PEEK intervertebral spacers and two NuVasive Advanced Materials Science portfolio implants.

Here are three things to know:

1. Patients will undergo a one- or two-level XLIF procedure with smooth PEEK, Modulus 3D-printed titanium or Cohere Porous PEEK implants.

2. The study will also generate level 1 biologic outcome evidence, as each implant group will have randomization between Osteocel Pro and cancellous allograft chips with bone marrow aspirate

3. In this two-year, follow-up study, at least 10 surgeons will assess the fusion progression in approximately 300 U.S. patients.

More articles on surface technology:
Nexxt Spine starts 1st trial of 3D-printed lumbar interbody fusion device vs. PEEK: 4 notes
Captiva Spine earns FDA clearance for 3D-printed titanium cervical cages: 3 insights
CoreLink launches expandable interbody fusion device: 3 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months